We noted that human acute promyelocytic leukemia (APL) samples, a subtype of AML initiated by the PML::RARA fusion gene (48, 49), had markedly higher expression of GAB2 than most other AMLs (Figure 8A) (7). This evidence concerns the gene GAB2 and acute myeloid leukemia.